Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03488914 · ClinicalTrials.gov registry record · NA

Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

A NA study of Substance Use and Sexual Risk, sponsored by Hunter College of City University of New York.

Completed
Registry status
NA
Development phase
86
Enrollment target
2
Study locations

NCT03488914 is a NA study of Substance Use and Sexual Risk that has completed, run by Hunter College of City University of New York. The registered enrollment target is 86 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03488914, a NA study of Substance Use and Sexual Risk, has completed, sponsored by Hunter College of City University of New York.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
2
Study locations

Study Summary

This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.

Interventions

  • BEHAVIORAL YMHP Intervention
  • BEHAVIORAL Enhanced Treatment as Usual

Study Locations (2)

New York

  • Bridging Access to Care - Brooklyn
  • BOOM!Health - The Bronx

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2016-06-15
Est. Completion 2021-04-30
Phase NA

What the Registry Record Tells You About NCT03488914

The ClinicalTrials.gov registry entry for NCT03488914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower). The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which YMHP Intervention is the first listed.

NCT03488914 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03488914 about?

NCT03488914 is a clinical study titled "Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color". This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.

What is the current status of trial NCT03488914?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2016-06-15. Estimated completion is 2021-04-30.

What conditions does trial NCT03488914 study?

This clinical trial studies the following conditions: Substance Use, Sexual Risk.

What interventions are being tested in trial NCT03488914?

The interventions under investigation include: YMHP Intervention (BEHAVIORAL), Enhanced Treatment as Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT03488914?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03488914 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.